CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-02 | Megna Michael R CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −16,670 | $19.17 | $320K | 17,005 |
| 2024-01-02 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Share Option 10b5-1 | −16,670 | 4,014 | ||
| 2023-12-19 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise 10b5-1 | +9,316 | $13.88 | $129K | 26,321 |
| 2023-12-19 | Megna Michael R CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −9,316 | $19.13 | $178K | 17,005 |
| 2023-12-19 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Share Option 10b5-1 | −9,316 | 20,684 | ||
| 2023-12-07 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +28,600 | $1.86 | $53K | 73,492 |
| 2023-12-07 | Paolini John F. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −7,380 | $17.54 | $129K | 66,112 |
| 2023-12-07 | Paolini John F. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −13,017 | $17.64 | $230K | 53,095 |
| 2023-12-07 | Paolini John F. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −6,702 | $17.75 | $119K | 46,393 |
| 2023-12-07 | Paolini John F. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −1,501 | $17.81 | $27K | 44,892 |
| 2023-12-07 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise · Share Option 10b5-1 | −28,600 | 111,217 | ||
| 2023-11-03 | Levy Richard S Director | Option exercise | +2,777 | 7,777 | ||
| 2023-11-03 | Levy Richard S Director | Grant or award · Restricted Share Units | +2,777 | 2,777 | ||
| 2023-11-03 | Levy Richard S Director | Option exercise · Restricted Share Units | −2,777 | 0 | ||
| 2023-10-04 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise | +175 | 17,057 | ||
| 2023-10-04 | Megna Michael R CHIEF ACCOUNTING OFFICER | Shares withheld for taxes | −52 | $16.01 | $833 | 17,005 |
| 2023-10-04 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Restricted Share Unit | −175 | 350 | ||
| 2023-09-05 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +400 | $1.86 | $744 | 45,292 |
| 2023-09-05 | Paolini John F. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −400 | $17.53 | $7K | 44,892 |
| 2023-09-05 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise · Share Option 10b5-1 | −400 | 139,817 |
Page 56 of 74 · 1,467 trades